Tenmizu FinTech

視陽 6782

Listed · Biotechnology and medical care
Backtest

Sign up to add 視陽 to your watchlist

Sign up to use the watchlist, price alerts and backtests, and keep your personalised settings.

Continue to sign up or sign in

Already have an account? Sign in

282.5▼-5.5 (-1.91%)After close
Prev close
288
Volume (shares)
901,923
Data time
2026-11-11 13:30:00
Open
296.00
High
296.00
Low
276.00
Prev close
288.00
Volume (lots)
902
Turnover
2.56 億
P/E
15.1
Cash yield
2.97%

Financial trends

Loading…

Consolidated statements; NT$100M (per-share items in NT$). Updated after each quarterly filing (MOPS). Some line items do not apply to financial companies.

Unit: 100 million TWD (EPS in TWD)Source: public data from MOPS, TWSE, TPEx and TDCC

Loading…

Figures are shown as announced, with no scoring or rating.

Metric2026 Q32026 Q22026 Q12025 Q42025 Q32025 Q22025 Q12024 Q4
Gross margin46.67%48.79%45.82%46.97%46.22%46.55%40.62%37.53%
Operating margin27.57%29.92%28.11%29.33%29.77%28.32%21.06%19.11%
Net margin27.38%23.11%19.58%23.45%22.58%17.35%20.47%13.39%
ROE (TTM)26.82%25.97%23.74%21.85%19.69%20.84%19.88%19.11%
ROA (TTM)16.87%16.82%15.65%15.69%13.29%13.14%12.50%12.73%
EPS, quarter (TWD)6.324.633.823.984.062.963.081.96
EPS, TTM (TWD)18.7516.4914.8214.0812.0611.1510.4810.10

No data.

Revenue in NT$100M; 12 months per page.

No data.

Amounts in NT$100M (per-share items in NT$).

No data.

Amounts in NT$100M (per-share items in NT$).

No data.

Amounts in NT$100M (per-share items in NT$).

Metric2026 Q32026 Q22026 Q12025 Q42025 Q32025 Q22025 Q12024 Q4
Current ratio109.48%110.57%——————
Debt ratio40.57%35.02%32.69%25.97%31.56%34.81%34.90%29.92%
Equity ratio59.43%64.98%67.31%74.03%68.44%65.19%65.10%70.08%
Equity multiplier1.681.541.491.351.461.531.541.43

Metric2026 Q32026 Q22026 Q12025 Q42025 Q32025 Q22025 Q12024 Q4
Asset turnover (TTM revenue / avg. assets)0.720.760.760.750.710.740.720.73
Equity turnover1.131.171.141.041.051.171.141.10

Source: MOPS. For reference only; not investment advice.